DUBLIN--(BUSINESS WIRE)--May. 23, 2013--
Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the Deutsche Bank 38th Annual
dbAccess Health Care Conference on Wednesday, May 29, 2013, at 8:40 a.m.
EDT (1:40 p.m. BST) from The Westin Boston Waterfront Hotel. The
presentation may be accessed under the Investors tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
that applies its scientific expertise and proprietary technologies to
develop innovative medicines that improve patient outcomes. The company
has a diversified portfolio of more than 20 commercial drug products and
a substantial clinical pipeline of product candidates that address
central nervous system (CNS) disorders such as addiction, schizophrenia
and depression. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and manufacturing facilities in
Gainesville, Georgia and Wilmington, Ohio. For more information, please
visit Alkermes’ website at www.alkermes.com.
Source: Alkermes plc
Alkermes plc
Eva Stroynowski, +1 781 609 6823
Corporate
Communications
